Delivery Order SPE2DB25D3012-SPE2DB25FWWAN
Award Date 3/11/25
Potential Completion Date 3/12/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,556 units of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count bottles. The $1,418.22 firm-fixed price delivery order has an ultimate completion date of August 26, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,116.42, is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in 1,000-count units. The contract is a Firm Fixed Price Delivery Order with a period of performance running through March 14, 2025. The contract was not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
- This federal contract award is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count sizes. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,150.62. The contract is for a fixed price and has an ultimate completion date of June 24, 2025. The contract is not set aside for any specific small business designation. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets. The contract has a ceiling value of $2,069.52 and an ultimate completion date of April 25, 2023. The contract is a Delivery Order under the firm fixed price pricing type. It is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FN1M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,156.33 firm fixed-price delivery order is for the supply of 4,564,043,828 units of the drug Lisinopril-HCTZ 10-12.5 mg tablets. The contract has a completion date of March 22, 2024 and was awarded on March 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,261.68 fixed-price delivery order is for the supply of Lisinopril-Hydrochlorothiazide 20-25 mg tablets. The contract has an ultimate completion date of October 15, 2024 and is not set aside for any special designation. Amerisourcebergen is a significant vendor for the DLA, holding a $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,048.21, is for the supply of Lisinopril-HCTZ 10-12.5 mg tablets in 1,000 tablet quantities. The contract has an ultimate completion date of August 13, 2024 and is a Firm Fixed Price contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of lisinopril 40 mg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract has a Ceiling Value of $1,178.28 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...